Product Information
DROXIDOPA 200 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8820 per EA under NDC 70710139009. Its NADAC has been published 175 times since Feb 22, 2023.
FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710139009
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA211818FDA Approved
2/18/2021
TE Code
AB
On Market Since
2/19/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 200 MG CAPSULE has been published 175 times since Feb 22, 2023, and over the history we have for it it has declined 58.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8820 per EA |
|---|---|
| All-time high | $2.3453 (Jul 10, 2024) |
| All-time low | $0.8820 (Aug 19, 2026) |
| 52-week high | $1.7346 |
| 52-week low | $0.8820 |
| Median price | $1.7346 |
| Average price | $1.7728 |
| Largest weekly change | -25.1% (Jul 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROXIDOPA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8820 per EA (NDC 70710139009), effective Aug 19, 2026.
How has the price of DROXIDOPA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 58.6%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?
Since Feb 22, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $0.8820 (Aug 19, 2026) to a high of $2.3453 (Jul 10, 2024), with a median of $1.7346 per EA.
Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROXIDOPA 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DROXIDOPA 200 MG CAPSULE?
DROXIDOPA 200 MG CAPSULE (NDC 70710139009) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.